Table 2: Obstetric data of study participants.
N (%) |
Non-contraceptive users (n = 222) |
DMPA (N = 88) |
Etonogestrel implant (n = 87) |
Desogestrel pills (n = 47) |
P-Value |
Previous abortion |
16 (7.2) |
5 (5.7) |
6 (6.9) |
4 (8.5) |
0.937 |
Lactation |
153 (68.9) |
63 (71.6) |
59 (67.8) |
32 (68.1) |
0.951 |
Number of living children |
|||||
1-2 |
106 (47.7) |
43 (48.9) |
38 (43.7) |
18 (38.3) |
|
3 or more |
116 (52.3) |
45 (51.1) |
49 (56.3) |
29 (61.7) |
0.600 |
Parity |
|||||
≤ 3 |
96 (43.2) |
36 (40.9) |
46 (52.9) |
25 (53.2) |
|
> 3 |
126 (56.8) |
52 (59.1) |
41 (47.1) |
22 (46.8) |
0.239 |
Mode of delivery |
|||||
Cesarean section |
107 (48.2) |
45 (51.1) |
47 (54.0) |
26 (55.3) |
|
Normal vaginal delivery |
54 (24.3) |
29 (33.0) |
24 (27.6) |
15 (31.9) |
|
Vaginal delivery with episiotomy |
61 (27.5) |
14 (15.9) |
16 (18.4) |
6 (12.8) |
0.140 |
DMPA: Depot Medroxyprogesterone Acetate; N (%) number and percentage.